Total Payments
$1,812
2024 Payments
$414.52
Companies
18
Transactions
91
Medicare Patients
2,404
Medicare Billing
$454,519
Payment Breakdown by Category
Food & Beverage$1,724 (95.1%)
Education$88.50 (4.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,724 | 76 | 95.1% |
| Education | $88.50 | 15 | 4.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $561.80 | 7 | $0 (2024) |
| Amarin Pharma Inc. | $311.45 | 23 | $0 (2021) |
| Novo Nordisk Inc | $182.61 | 26 | $0 (2019) |
| Valeant Pharmaceuticals North America LLC | $172.75 | 10 | $0 (2017) |
| Alcon Vision LLC | $132.14 | 1 | $0 (2024) |
| ABBVIE INC. | $63.48 | 3 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $58.59 | 4 | $0 (2023) |
| Avedro Inc. | $58.30 | 1 | $0 (2018) |
| GlaxoSmithKline, LLC. | $57.73 | 3 | $0 (2024) |
| Hikma Pharmaceuticals USA | $43.28 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $414.52 | 8 | AstraZeneca Pharmaceuticals LP ($193.81) |
| 2023 | $263.71 | 5 | AstraZeneca Pharmaceuticals LP ($209.05) |
| 2022 | $295.08 | 10 | AstraZeneca Pharmaceuticals LP ($158.94) |
| 2021 | $39.26 | 3 | Amarin Pharma Inc. ($24.83) |
| 2020 | $50.67 | 3 | GlaxoSmithKline, LLC. ($21.67) |
| 2019 | $317.61 | 24 | Amarin Pharma Inc. ($270.24) |
| 2018 | $71.91 | 2 | Avedro Inc. ($58.30) |
| 2017 | $359.47 | 36 | Valeant Pharmaceuticals North America LLC ($172.75) |
All Payment Transactions
91 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/21/2024 | Alcon Vision LLC | DAILIES TOTAL1 (Device) | Food and Beverage | In-kind items and services | $132.14 | General |
| Category: Ophthalmology | ||||||
| 11/14/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $21.48 | General |
| Category: RESPIRATORY | ||||||
| 08/09/2024 | ABBVIE INC. | AVYCAZ (Drug), TEFLARO, DALVANCE | Food and Beverage | In-kind items and services | $31.51 | General |
| Category: ANTI-INFECTIVE | ||||||
| 03/20/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $100.00 | General |
| Category: Respiratory | ||||||
| 02/27/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: RESPIRATORY | ||||||
| 01/30/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: Respiratory | ||||||
| 01/23/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $78.09 | General |
| Category: Respiratory | ||||||
| 01/11/2024 | ATRICURE, INC. | ATRICLIP LAA EXCLUSION SYSTEM (Device) | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/28/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: NEUROSCIENCE | ||||||
| 03/29/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/27/2023 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $24.60 | General |
| Category: General - Pain Management_NMD | ||||||
| 02/15/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.08 | General |
| Category: Gastroenterology | ||||||
| 01/12/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $84.05 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/17/2022 | Kowa Pharmaceuticals America, Inc. | Seglentis (Drug) | Food and Beverage | Cash or cash equivalent | $16.14 | General |
| Category: Pain Management | ||||||
| 11/15/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: NEUROSCIENCE | ||||||
| 10/18/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $129.87 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/10/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $29.07 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/14/2022 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $12.93 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/27/2022 | Hikma Pharmaceuticals USA | Mitigare (Drug) | Food and Beverage | In-kind items and services | $19.37 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/13/2022 | Kowa Pharmaceuticals America, Inc. | Seglentis (Drug) | Food and Beverage | Cash or cash equivalent | $15.08 | General |
| Category: Pain Management | ||||||
| 02/14/2022 | Nestle HealthCare Nutrition Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $18.20 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 02/07/2022 | Hikma Pharmaceuticals USA | Mitigare (Drug) | Food and Beverage | In-kind items and services | $23.91 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/31/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: Gastroenterology | ||||||
| 08/26/2021 | Althera Pharmaceuticals LLC | Roszet (Drug) | Food and Beverage | In-kind items and services | $7.89 | General |
| Category: Cardiovascular | ||||||
| 08/26/2021 | Althera Pharmaceuticals LLC | Roszet (Drug) | Food and Beverage | In-kind items and services | $6.54 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 598 | 1,559 | $217,055 | $118,868 |
| 2022 | 12 | 544 | 1,373 | $198,070 | $103,181 |
| 2021 | 14 | 603 | 1,357 | $199,160 | $108,444 |
| 2020 | 15 | 659 | 1,681 | $238,105 | $124,026 |
Total Patients
2,404
Total Services
5,970
Medicare Billing
$454,519
Procedure Codes
52
All Medicare Procedures & Services
52 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 132 | 854 | $111,020 | $54,571 | 49.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 66 | 187 | $23,375 | $15,941 | 68.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 124 | 150 | $26,250 | $15,704 | 59.8% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 125 | 150 | $22,500 | $9,730 | 43.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 55 | 55 | $6,875 | $6,738 | 98.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 29 | 48 | $7,200 | $5,261 | 73.1% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 12 | 16 | $6,400 | $3,564 | 55.7% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 21 | 62 | $6,180 | $2,495 | 40.4% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 11 | 11 | $2,035 | $1,838 | 90.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 12 | 12 | $2,700 | $1,681 | 62.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 11 | 14 | $2,520 | $1,346 | 53.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 96 | 733 | $95,290 | $42,221 | 44.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 83 | 221 | $27,625 | $18,368 | 66.5% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 72 | 87 | $15,225 | $9,408 | 61.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 61 | 61 | $7,625 | $7,526 | 98.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 92 | 111 | $16,650 | $6,468 | 38.8% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 14 | 18 | $7,200 | $4,104 | 57.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 23 | 36 | $5,400 | $4,084 | 75.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 21 | 21 | $4,725 | $3,260 | 69.0% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 19 | 19 | $4,750 | $2,749 | 57.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 23 | 26 | $4,680 | $2,154 | 46.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 19 | 19 | $5,225 | $1,621 | 31.0% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 21 | 21 | $3,675 | $1,217 | 33.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 105 | 654 | $85,020 | $38,364 | 45.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 95 | 203 | $25,375 | $17,578 | 69.3% |
About Dr. James Tran, MD
Dr. James Tran, MD is a Internal Medicine healthcare provider based in Pasadena, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1477665966.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Tran, MD has received a total of $1,812 in payments from pharmaceutical and medical device companies, with $414.52 received in 2024. These payments were reported across 91 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($1,724).
As a Medicare-enrolled provider, Tran has provided services to 2,404 Medicare beneficiaries, totaling 5,970 services with total Medicare billing of $454,519. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Pasadena, TX
- Active Since 08/31/2006
- Last Updated 01/13/2010
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1477665966
Products in Payments
- FARXIGA (Drug) $367.99
- Vascepa (Drug) $311.45
- XIFAXAN (Drug) $218.72
- AIRSUPRA (Drug) $193.81
- Victoza (Drug) $167.08
- DAILIES TOTAL1 (Device) $132.14
- Photrexa (Drug) $58.30
- AVYCAZ (Drug) $47.61
- Mitigare (Drug) $43.28
- TRELEGY ELLIPTA (Drug) $36.25
- Seglentis (Drug) $31.22
- ELIQUIS (Drug) $30.08
- AREXVY (Drug) $21.48
- ATRICLIP LAA EXCLUSION SYSTEM (Device) $21.00
- ZENPEP (Drug) $18.20
- QULIPTA (Drug) $15.99
- VRAYLAR (Drug) $15.98
- Tresiba (Drug) $15.53
- Roszet (Drug) $14.43
- RELISTOR (Drug) $12.62
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Pasadena
Dr. Yuan Yuan, M.d., Ph.d, M.D., PH.D
Internal Medicine — Payments: $523,801
Internal Medicine $523,801
Christopher Dagher, M.d, M.D
Internal Medicine — Payments: $103,615
Internal Medicine $103,615
Peter Haddad, M.d, M.D
Internal Medicine — Payments: $87,600
Internal Medicine $87,600
Dr. Andrew Williams, M.d, M.D
Internal Medicine — Payments: $85,273
Internal Medicine $85,273
Joseph Dellinger, Md, MD
Internal Medicine — Payments: $77,175
Internal Medicine $77,175
Dr. Helen Moon, M.d, M.D
Internal Medicine — Payments: $61,882
Internal Medicine $61,882